DHI

DR Horton
D

DHI

Arincen55/100B

If you had invested in DR Horton ago, it would be worth $5,932 today, against $4,096 in SPY and $6,368 in QQQ.

ArincenArincen ScoreBeta

55/100

Six parts of the company, five checks each, from its own reported figures. A part scores the checks it passes out of 10; the score is their average out of 100.

Profitability2

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Cash10

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Valuation5

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Growth2

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Financial strength8

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Shareholders6

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Figures to FY2026; the price as of today.

DR Horton key facts

Style
Value stock · 6.2/10Growth 2.9 · Value 6.2 · Dividend 4.8
Day range
143.100 – 145.000
52-week range
130.400 – 170.790
Market capitalization
38.94B USD
P/E
14.15
PEG ratio
2.37
EPS
10.14
Div Yield
1.39%
EPS growth forecast (FY2027)
-15.5%
Volume
8,209
Beta
1.37
ESG score
58.7/100Environment 52 · Social 53 · Governance 71
Sector
Consumer Cyclical
Industry
Residential Construction
CEO
Paul J. Romanowski
Employees
14K
IPO date
5 Jun 1992

DR Horton earnings

Next earnings · Q1 FY2027
EPS estimate
1.33 USD
Revenue estimate
6.07B USD
Last quarter · Q4 FY2026
EPS2.67Missed -11.3%Revenue9.37BBeat +3.3%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q4 FY20272.85——+6.56%9.04B——-3.54%
Q3 FY20272.67——-16.66%8.66B——-6.12%
Q2 FY20271.86——-16.88%7.29B——-3.61%
Q1 FY20271.33——-34.48%6.07B——-11.89%
Q4 FY20263.012.67-11.30%-12.17%9.07B9.37B+3.32%-3.17%
Q3 FY20263.023.20+5.96%-4.76%9.10B9.23B+1.44%+0.02%
Q2 FY20262.152.24+4.19%-13.18%7.55B7.56B+0.11%-2.27%
Q1 FY20261.932.03+5.18%-22.22%6.59B6.89B+4.56%-9.54%
Q4 FY20253.273.04-7.03%-22.45%9.41B9.68B+2.81%-3.25%
Q3 FY20252.943.36+14.29%-18.05%8.77B9.23B+5.14%-7.43%

Analysts' estimates for FY2027 over the last 7 days:EPS Revenue How the estimates moved

DR Horton analyst forecast

12-month price target
157.17 USD
+9.56%

Analysts' 1-year price targets range from 130.00 to 182.00, with an average of 157.17.

Past year
1-year forecast
Strong sellStrong buy
Hold
16 ratings
Buy
4
Hold
10
Sell
2

12-month price target

Highest target182.00
Average target157.17
Lowest target130.00
Current price143.45

DR Horton valuation

Price to earnings ratio (TTM)
14.15
Forward P/E (FY2027)
16.74
Price to sales (TTM)
1.18
Price to book
1.68
EV / EBITDA (TTM)
10.95

Capital structure

Market capitalization
38.94B USD
+
Total debt
6.05B USD
−
Cash and short-term investments
2.06B USD
=
Enterprise value
42.93B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2029 (est.)11.93————
FY2028 (est.)13.6711.93———
FY2027 (est.)16.7413.67———
Now (TTM)14.1516.301.181.6810.95
FY202613.4815.941.181.6810.67
FY202514.5816.231.532.1611.43
FY202413.2116.151.712.4810.09
FY20237.726.691.031.615.91
FY20224.055.060.711.223.54

DR Horton against its own history

Each figure in the latest fiscal year against the same figure from FY2022 to FY2026: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: PulteGroup, Lennar, NVR, Toll Brothers, Installed Building Products, and Champion Homes, the US Residential Construction companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • P/E (today)Above its median14.1
    4.315.6
  • Gross marginLowest in 5 years22.3%
    22.3%31.4%
    Against its peers: 6 of 7Peers' median 26.2%
  • Operating marginLowest in 5 years10.9%
    10.9%23.0%
    Against its peers: 5 of 7Peers' median 14.3%
  • Net marginLowest in 5 years8.7%
    8.7%17.5%
    Against its peers: 5 of 7Peers' median 10.6%
  • Return on equityLowest in 5 years12.5%
    12.5%30.2%
    Against its peers: 6 of 7Peers' median 16.7%
  • Free cash flow marginAbove its median10.1%
    1.2%11.7%
    Against its peers: 2 of 7Peers' median 10.1%
  • Revenue growthBelow its median-3.5%
    -6.9%20.5%
    Against its peers: 5 of 7Peers' median -0.5%
  • EPS growthAt its median-12.6%
    -19.3%44.6%
    Against its peers: 4 of 7Peers' median -12.0%
  • Debt to EBITDAHighest in 5 years1.50×
    0.79×1.50×
    Against its peers: 4 of 7Peers' median 1.18×
  • Current ratioHighest in 5 years26.69
    13.1326.69
    Against its peers: 1 of 7Peers' median 3.54

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

DR Horton growth and profitability

Revenue (TTM)
33.04B USD
Net income (TTM)
2.89B USD
Gross margin
22.28%
Operating margin
11.41%
Net margin
8.74%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY202633.04B-3.52%2.89B-19.41%22.28%10.93%8.74%4.02B-16.91%
FY202534.25B-6.93%3.59B-24.62%23.70%12.92%10.47%4.84B-24.02%
FY202436.80B+3.78%4.76B+0.23%25.91%16.61%12.92%6.37B-0.54%
FY202335.46B+5.92%4.75B-18.98%26.37%17.60%13.38%6.41B-16.92%
FY202233.48B+20.54%5.86B+40.27%31.37%23.02%17.50%7.71B+42.00%

DR Horton revenue breakdown

By product

FY2025
Homebuilding: 88.4%Forestar Group: 4.7%Rental: 4.6%Financial Services: 2.4%88.4%Homebuilding4.7%Forestar Group4.6%Rental2.4%Financial Services
SegmentRevenueShare of revenueChange on the year
Homebuilding31.52B88.4%-7.2%
Forestar Group1.66B4.7%+10.1%
Rental1.64B4.6%-2.7%
Financial Services841.20M2.4%-4.7%

By region

FY2025
Southeast: 22.1%South Central: 21.9%East: 19.5%Southwest: 14.6%North: 13.4%Northwest: 8.5%22.1%Southeast21.9%South Central19.5%East14.6%Southwest13.4%North8.5%Northwest
RegionRevenueShare of revenueChange on the year
Southeast6.97B22.1%-21.5%
South Central6.90B21.9%-9.8%
East6.14B19.5%+1.1%
Southwest4.60B14.6%-6.5%
North4.23B13.4%+14.7%
Northwest2.69B8.5%-2.7%

How DR Horton makes its money

Revenue33.04B 100.0%
Cost of revenue25.68B 77.7%
Gross profit7.36B 22.3%
Selling and administration3.75B 11.3%
Operating income3.61B 10.9%
Tax968.80M 2.9%
Net income2.89B 8.7%

FY2026, in USD. Each band is as wide as its money; the percentage is its share of revenue.

DR Horton dividends

Annual dividend
2.00 USD
Dividend yield (indicated)
1.39%
Payout ratio
18.24%
Years of dividend growth
12
Frequency
Quarterly
Next payment
0.50 USD
Last ex-dividend date
12 Nov 2026
Next payment date
19 Nov 2026

Dividends per share

Year2025202420232022202120202019201820172016
Dividends per share1.651.301.050.930.830.730.630.530.430.34

DR Horton financial health

Cash and short-term investments
2.06B USD
Total debt
6.05B USD
Net cash
-3.99B USD
Free cash flow (TTM)
3.35B USD
Current ratio
26.69
Debt to equity
0.26
Piotroski score
6 / 9
Altman Z-score
5.87

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY20262.06B6.05B3.35B
FY20252.99B6.03B3.28B
FY20244.52B5.97B2.02B
FY20233.87B5.14B4.16B
FY20222.54B6.11B413.60M

DR Horton ownership

Institutions
84.95%
Institutional holders
1,296 (+87)
Free float
89.58%

Who owns the shares

Institutions 84.9% Others 15.1%
As of 30 Jun 2026

Shares free to trade

Free float 243.16M shares ·89.6% Closely held 28.27M shares ·10.4%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Insider trading

QuarterPurchasesSalesShares acquiredShares disposed of
Q3 202600792.005.79K
Q2 20260038.57K37.35K
Q1 20260120.44K35.39K
Q4 202500533.32K625.97K

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY2026284.80M285.80M-7.78%
FY2025308.50M309.90M-6.54%
FY2024329.50M331.60M-3.41%
FY2023340.70M343.30M-3.24%
FY2022351.70M354.80M-3.01%

Source: Financial Modeling PrepVerified against SEC filings

Related Instruments

Title: DR Horton

Sector: Consumer Cyclical
Industry: Residential Construction
D.R. Horton is the largest homebuilder in the United States with operations in 126 markets across 36 states. D.R. Horton mainly builds single-family homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxurybuyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. The firm has majority ownership of Forestar Group, a publicly traded residential lot development company. D.R. Horton's headquarters are in Arlington, Texas.

Common questions about DR Horton stock